ANTARES PHARMA, INC. Insider Trading for February 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ANTARES PHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ANTARES PHARMA, INC. for February 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | Powell Fred M | Executive Vice Pres ... | Payment of Exercise | F | 4.73 | 35,829 | 169,471 | 691,001 | 726.8 K to 691 K (-4.93 %) |
| Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | Powell Fred M | Executive Vice Pres ... | Grant | A | 0.00 | 80,365 | 0 | 726,830 | 646.5 K to 726.8 K (+12.43 %) |
| Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | M | 0.88 | 250,000 | 220,000 | 0 | |
| Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | M | 2.62 | 5,519 | 14,460 | 0 | |
| Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Sell | S | 5.00 | 241,960 | 1,209,800 | 2,204,760 | 2.4 M to 2.2 M (-9.89 %) |
| Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Sell | S | 5.01 | 17,844 | 89,398 | 2,446,720 | 2.5 M to 2.4 M (-0.72 %) |
| Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Sell | S | 5.00 | 232,156 | 1,160,780 | 2,464,564 | 2.7 M to 2.5 M (-8.61 %) |
| Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Buy | M | 0.88 | 250,000 | 220,000 | 2,696,720 | 2.4 M to 2.7 M (+10.22 %) |
| Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Sell | S | 4.75 | 5,519 | 26,215 | 2,446,720 | 2.5 M to 2.4 M (-0.23 %) |
| Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Buy | M | 2.62 | 5,519 | 14,460 | 2,452,239 | 2.4 M to 2.5 M (+0.23 %) |
| Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 4.73 | 116,313 | 550,160 | 2,446,720 | 2.6 M to 2.4 M (-4.54 %) |
| Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Grant | A | 0.00 | 267,878 | 0 | 2,563,033 | 2.3 M to 2.6 M (+11.67 %) |
| Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Option Exercise | M | 2.24 | 15,321 | 34,319 | 0 | |
| Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Sell | S | 5.05 | 15,321 | 77,371 | 253,042 | 268.4 K to 253 K (-5.71 %) |
| Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Buy | M | 2.24 | 15,321 | 34,319 | 268,363 | 253 K to 268.4 K (+6.05 %) |
| Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | GRAHAM PETER J | EVP General Counsel ... | Option Exercise | M | 1.12 | 45,000 | 50,400 | 0 | |
| Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | GRAHAM PETER J | EVP General Counsel ... | Sell | S | 5.05 | 5,000 | 25,250 | 540,417 | 545.4 K to 540.4 K (-0.92 %) |
| Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | GRAHAM PETER J | EVP General Counsel ... | Sell | S | 4.91 | 40,000 | 196,400 | 545,417 | 585.4 K to 545.4 K (-6.83 %) |
| Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | GRAHAM PETER J | EVP General Counsel ... | Buy | M | 1.12 | 45,000 | 50,400 | 585,417 | 540.4 K to 585.4 K (+8.33 %) |
| Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | GRAHAM PETER J | EVP General Counsel ... | Payment of Exercise | F | 4.73 | 42,073 | 199,005 | 540,417 | 582.5 K to 540.4 K (-7.22 %) |
| Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | GRAHAM PETER J | EVP General Counsel ... | Grant | A | 0.00 | 80,365 | 0 | 582,490 | 502.1 K to 582.5 K (+16.00 %) |
| Feb 12 2021 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | M | 1.12 | 50,000 | 56,000 | 0 | |
| Feb 12 2021 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Sell | S | 4.62 | 50,000 | 231,000 | 224,406 | 274.4 K to 224.4 K (-18.22 %) |
| Feb 12 2021 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Buy | M | 1.12 | 50,000 | 56,000 | 274,406 | 224.4 K to 274.4 K (+22.28 %) |
| Feb 10 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | M | 2.62 | 7,278 | 19,068 | 0 | |
| Feb 10 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | M | 2.62 | 49,129 | 128,718 | 0 | |
| Feb 10 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | M | 2.62 | 33,574 | 87,964 | 0 | |
| Feb 10 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Sell | S | 4.75 | 7,278 | 34,571 | 2,295,155 | 2.3 M to 2.3 M (-0.32 %) |
| Feb 10 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Buy | M | 2.62 | 7,278 | 19,068 | 2,302,433 | 2.3 M to 2.3 M (+0.32 %) |
| Feb 10 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Sell | S | 4.75 | 49,129 | 233,363 | 2,295,155 | 2.3 M to 2.3 M (-2.10 %) |
| Feb 10 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Buy | M | 2.62 | 49,129 | 128,718 | 2,344,284 | 2.3 M to 2.3 M (+2.14 %) |
| Feb 10 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Sell | S | 4.75 | 33,574 | 159,477 | 2,295,155 | 2.3 M to 2.3 M (-1.44 %) |
| Feb 10 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Buy | M | 2.62 | 33,574 | 87,964 | 2,328,729 | 2.3 M to 2.3 M (+1.46 %) |